-
Serum leukotriene B4 and hydroxyeicosatetraenoic acid in the prediction of pre-eclampsia.
Santos LL, Wertaschnigg D, Rolnik DL, Da Silva Costa F, Syngelaki A, Dimitriadis E, Nicolaides KH.
Placenta 2020;103:76-81. pdf -
Second- and third-trimester serum levels of growth-differentiation factor-15 in prediction of pre-eclampsia.
Wertaschnigg D, Rolnik DL, Nie G, Teoh SSY, Syngelaki A, da Silva Costa F, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;56:879-884. pdf -
Ophthalmic artery Doppler in combination with other biomarkers in the prediction of pre-eclampsia at 35-37 weeks' gestation.
Sarno M, Wright A, Vieira N, Sapantzoglou I, Charakida M, Nicolaides KH.
Ultrasound Obstet Gynecol 2021;57:600-606. pdf -
Galectin-7 Impairs Placentation and Causes Preeclampsia Features in Mice.
Menkhorst E, Zhou W, Santos LL, Delforce S, So T, Rainczuk K, Loke H, Syngelaki A, Varshney S, Williamson N, Pringle K, Young MJ, Nicolaides KH, St-Pierre Y, Dimitriadis E.
Hypertension 2020;76:1185-1194. pdf -
First-trimester screening for trisomies in pregnancies with vanishing twin.
Chaveeva P, Wright A, Syngelaki A, Konstantinidou L, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;55:326-331. pdf -
First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D, Biris D, Karampitsakos T, Nicolaides KK, Kametas NA.
Am J Obstet Gynecol 2020;222:374.e1-374.e9. pdf -
First trimester inflammatory mediators in women with chronic hypertension.
Nzelu D, Dumitrascu-Biris D, Karampitsakos T, Nicolaides KK, Kametas NA.
Acta Obstet Gynecol Scand 2020;99:1198-1205. pdf -
First trimester biomarkers for prediction of gestational diabetes mellitus.
Tenenbaum-Gavish K, Sharabi-Nov A, Binyamin D, Møller HJ, Danon D, Rothman L, Hadar E, Idelson A, Vogel I, Koren O, Nicolaides KH, Gronbaek H, Meiri H.
Placenta 2020;101:80-89. pdf -
Competing-risks model for prediction of small-for-gestational-age neonate from maternal characteristics and serum pregnancy-associated plasma protein-A at 11-13 weeks' gestation.
Papastefanou I, Wright D, Syngelaki A, Lolos M, Anampousi K, Nicolaides KH.
Ultrasound Obstet Gynecol 2020;56:541-548. pdf -
Two-stage approach for prediction of small-for-gestational-age neonate and adverse perinatal outcome by routine ultrasound examination at 35-37 weeks' gestation.
Akolekar R, Panaitescu AM, Ciobanu A, Syngelaki A, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;54:484-491. pdf -
Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
Ciobanu A, Rouvali A, Syngelaki A, Akolekar R, Nicolaides KH.
Am J Obstet Gynecol 2019;220:486.e1-486.e11. pdf -
Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A, Wright A, Panaitescu A, Syngelaki A, Wright D, Nicolaides KH.
Am J Obstet Gynecol 2019;220:584.e1-584.e11. pdf -
Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor.
Fiolna M, Machuca M, Karampitsakos T, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;54:604-608. pdf -
PlGF isoform 3 in maternal serum and placental tissue.
Frang H, Hurskainen P, Nicolaides K, Sairanen M.
Pregnancy Hypertens 2019;18:9-13. pdf -
First trimester combined screening in patients with systemic lupus erythematosus: impact of pre-analytical variables on risk assessment.
de Sousa MJR, Ribeiro R, Syngelaki A, Nicolaides KH.
Clin Rheumatol 2019;38:1251-1255. pdf -
Does first-trimester serum pregnancy-associated plasma protein A differ in pregnant women with sickle cell disease?
Peeva G, Oakley L, von Rège I, Nicolaides K, Oteng-Ntim E.
Prenat Diagn 2019;39:921-924. pdf -
Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Ciobanou A, Jabak S, De Castro H, Frei L, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2019;54:79-86. pdf -
Two-stage approach for risk estimation of fetal trisomy 21 and other aneuploidies using computational intelligence systems.
Neocleous AC, Syngelaki A, Nicolaides KH, Schizas CN.
Ultrasound Obstet Gynecol 2018;51:503-508. pdf -
Screening for pre-eclampsia at 35-37 weeks' gestation.
Panaitescu A, Ciobanu A, Syngelaki A, Wright A, Wright D, Nicolaides KH.
Ultrasound Obstet Gynecol 2018;52:501-506. pdf -
Predicting the Risk to Develop Preeclampsia in the First Trimester Combining Promoter Variant -98A/C of LGALS13 (Placental Protein 13), Black Ethnicity, Previous Preeclampsia, Obesity, and Maternal Age.
Madar-Shapiro L, Karady I, Trahtenherts A, Syngelaki A, Akolekar R, Poon L, Cohen R, Sharabi-Nov A, Huppertz B, Sammar M, Juhasz K, Than NG, Papp Z, Romero R, Nicolaides KH, Meiri H.
Fetal Diagn Ther 2018;43(4):250-265. pdf